PA
IHE icon

PFG Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

PFG Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,523
Closed -$328K – 814
2025
Q3 		$328K Buy
+4,523
New +$312K 0.01% 656

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFG Advisors's IHE Position: Q4 2025 in Review

PFG Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2025, closing a stake of 4,523 shares — an estimated $328K sold.

PFG Advisors first reported a position in IHE in Q3 2025 and held it in 1 quarter. The position peaked at $328K in Q3 2025. 178 funds tracked by Wall St. Rank hold IHE as of Q4 2025.

  • PFG Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2025 after selling out during the quarter.
  • PFG Advisors sold 4,523 iShares US Pharmaceuticals ETF shares in Q4 2025, an estimated $328K.
  • PFG Advisors first reported a position in iShares US Pharmaceuticals ETF in Q3 2025 and held it in 1 quarter.
  • PFG Advisors's iShares US Pharmaceuticals ETF position peaked at $328K in Q3 2025.
  • 178 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2025.

Based on PFG Advisors's 13F filing for Q4 2025, filed 27 Jan 2026.